BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7663534)

  • 1. Oxidative metabolism of bunitrolol by complementary DNA-expressed human cytochrome P450 isozymes in a human hepatoma cell line (Hep G2) using recombinant vaccinia virus.
    Ono S; Tsutsui M; Gonzalez FJ; Satoh T; Masubuchi Y; Horie T; Suzuki T; Narimatsu S
    Pharmacogenetics; 1995 Apr; 5(2):97-102. PubMed ID: 7663534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantioselectivity of bunitrolol 4-hydroxylation is reversed by the change of an amino acid residue from valine to methionine at position 374 of cytochrome P450-2D6.
    Narimatsu S; Kato R; Horie T; Ono S; Tsutsui M; Yabusaki Y; Ohmori S; Kitada M; Ichioka T; Shimada N; Kato R; Ishikawa T
    Chirality; 1999; 11(1):1-9. PubMed ID: 9914647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
    Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
    Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 3-methylcholanthrene on bunitrolol metabolism. Kinetics and immunological studies on 4-hydroxylation of bunitrolol catalyzed by two species of cytochromes P450 in rat liver microsomes.
    Fujita S; Masuda M; Shimamoto Y; Hoshi H; Kariya S; Kazusaka A; Suzuki T
    Drug Metab Dispos; 1996 Feb; 24(2):254-9. PubMed ID: 8742239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of carteolol by cDNA-expressed human cytochrome P450.
    Kudo S; Uchida M; Odomi M
    Eur J Clin Pharmacol; 1997; 52(6):479-85. PubMed ID: 9342584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
    Minoletti C; Dijols S; Dansette PM; Mansuy D
    Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone.
    Shou M; Korzekwa KR; Brooks EN; Krausz KW; Gonzalez FJ; Gelboin HV
    Carcinogenesis; 1997 Jan; 18(1):207-14. PubMed ID: 9054608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cDNA-expressed human cytochromes P450 in the metabolism of diazepam.
    Yang TJ; Shou M; Korzekwa KR; Gonzalez FJ; Gelboin HV; Yang SK
    Biochem Pharmacol; 1998 Mar; 55(6):889-96. PubMed ID: 9586962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.
    Shou M; Krausz KW; Gonzalez FJ; Gelboin HV
    Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics.
    Patten CJ; Thomas PE; Guy RL; Lee M; Gonzalez FJ; Guengerich FP; Yang CS
    Chem Res Toxicol; 1993; 6(4):511-8. PubMed ID: 8374050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs.
    Mancy A; Antignac M; Minoletti C; Dijols S; Mouries V; Duong NT; Battioni P; Dansette PM; Mansuy D
    Biochemistry; 1999 Oct; 38(43):14264-70. PubMed ID: 10572000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselectivity in bunitrolol 4-hydroxylation in liver microsomes from marmosets and Japanese monkeys.
    Narimatsu S; Gotoh M; Masubuchi Y; Horie T; Ohmori S; Kitada M; Kageyama T; Asaoka K; Yamamoto I; Suzuki T
    Biol Pharm Bull; 1996 Nov; 19(11):1429-33. PubMed ID: 8951158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol.
    Shou M; Korzekwa KR; Crespi CL; Gonzalez FJ; Gelboin HV
    Mol Carcinog; 1994 Jul; 10(3):159-68. PubMed ID: 8043197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene.
    Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV
    Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450.
    Chang TK; Gonzalez FJ; Waxman DJ
    Arch Biochem Biophys; 1994 Jun; 311(2):437-42. PubMed ID: 8203907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology.
    Yoshitomi S; Ikemoto K; Takahashi J; Miki H; Namba M; Asahi S
    Toxicol In Vitro; 2001 Jun; 15(3):245-56. PubMed ID: 11377097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytochrome P-450 metabolism of retinals to retinoic acids.
    Zhang QY; Dunbar D; Kaminsky L
    Drug Metab Dispos; 2000 Mar; 28(3):292-7. PubMed ID: 10681373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation.
    Kudo S; Odomi M
    Eur J Clin Pharmacol; 1998 May; 54(3):253-9. PubMed ID: 9681669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.